Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611881 · ClinicalTrials.gov registry record · Phase 4
Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 642
- Enrollment target
NCT03611881: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT03611881 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 642 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03611881, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 642 participants
- Enrollment target
Study Summary
This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.
Interventions
- BEHAVIORAL Counseling
- DRUG Nicotine patch
- BEHAVIORAL Community Resource
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03611881
The ClinicalTrials.gov registry entry for NCT03611881 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 642 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Counseling is the first listed.
NCT03611881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03611881 about?
NCT03611881 is a clinical study titled "Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)". This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these i...
What is the current status of trial NCT03611881?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 642 participants. The study started on 2019-04-01. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03611881?
The interventions under investigation include: Counseling (BEHAVIORAL), Nicotine patch (DRUG), Community Resource (BEHAVIORAL).
Who is sponsoring clinical trial NCT03611881?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.